{"altmetric_id":1338787,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":3},"twitter":{"unique_users_count":3,"unique_users":["yudejavu","lomu_j","stanleydandrea"],"posts_count":3}},"selected_quotes":["Fewer ODAC mtgs.Pazdur impressed by quality of drugs.Not a good sign for Tivo $AVEO"],"citation":{"altmetric_jid":"4f6fa5ea3cf058f610005bde","authors":["Peggy Eastman"],"doi":"10.1097\/01.cot.0000429350.41044.2e","first_seen_on":"2013-04-04T15:29:25+00:00","issns":["0276-2234"],"issue":"7","journal":"Oncology times","last_mentioned_on":1365101095,"links":["http:\/\/journals.lww.com\/oncology-times\/Fulltext\/2013\/04100\/Fewer_ODAC_Meetings__It_s_Not_Your_Imagination_.10.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/oncology-times\/2013\/04100\/Fewer_ODAC_Meetings__It_s_Not_Your_Imagination_.10.pdf","pubdate":"2013-04-10T00:00:00+00:00","startpage":"19","title":"Fewer ODAC Meetings? It's Not Your Imagination!","type":"article","volume":"35"},"altmetric_score":{"score":2.2,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.2},"context_for_score":{"all":{"total_number_of_other_articles":4505030,"mean":5.0987896285659,"rank":1754994,"this_scored_higher_than_pct":60,"this_scored_higher_than":2743433,"rank_type":"exact","sample_size":4505030,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":89202,"mean":6.63791459737,"rank":30273,"this_scored_higher_than_pct":65,"this_scored_higher_than":58734,"rank_type":"exact","sample_size":89202,"percentile":65},"this_journal":{"total_number_of_other_articles":1048,"mean":2.9468691499522,"rank":379,"this_scored_higher_than_pct":63,"this_scored_higher_than":664,"rank_type":"exact","sample_size":1048,"percentile":63},"similar_age_this_journal_3m":{"total_number_of_other_articles":45,"mean":2.6659090909091,"rank":14,"this_scored_higher_than_pct":68,"this_scored_higher_than":31,"rank_type":"exact","sample_size":45,"percentile":68}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Scientists":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/yudejavu\/statuses\/319883296379113473","license":"datasift","rt":["lomu_j"],"citation_ids":[1338787],"posted_on":"2013-04-04T18:44:55+00:00","author":{"name":"D.V.","image":"https:\/\/pbs.twimg.com\/profile_images\/1320955351\/DejanV_normal.jpg","description":"Teaches Administrative Law at University of Nis, Serbia.","id_on_source":"yudejavu","tweeter_id":"39519277","geo":{"lt":null,"ln":null},"followers":173},"tweet_id":"319883296379113473"},{"url":"http:\/\/twitter.com\/lomu_j\/statuses\/319834011218362369","license":"datasift","citation_ids":[1338787],"posted_on":"2013-04-04T15:29:05+00:00","author":{"name":"M","image":"https:\/\/pbs.twimg.com\/profile_images\/3451258109\/6f9bb8881027745473b22d4f74738815_normal.jpeg","description":"Biotech investor","id_on_source":"lomu_j","tweeter_id":"43475268","geo":{"lt":null,"ln":null},"followers":7736},"tweet_id":"319834011218362369"},{"url":"http:\/\/twitter.com\/stanleydandrea\/statuses\/319834738800082944","license":"datasift","rt":["lomu_j"],"citation_ids":[1338787],"posted_on":"2013-04-04T15:31:58+00:00","author":{"name":"Stan D'Andrea","image":"https:\/\/pbs.twimg.com\/profile_images\/1624257475\/image_normal.jpg","description":"Private investor, biotech. PhD in organic chemistry. Medicinal chemist for 22 years in big pharma. Novice trader","id_on_source":"stanleydandrea","tweeter_id":"187196936","geo":{"lt":41.45704,"ln":-72.82316,"country":"US"},"followers":1232},"tweet_id":"319834738800082944"}]}}